Effects of aquatic high-intensity interval training on aerobic capacity in adults with rheumatic and musculoskeletal diseases: the AquaHigh randomised controlled trial

水中高强度间歇训练对患有风湿病和肌肉骨骼疾病的成年人有氧能力的影响:AquaHigh随机对照试验

阅读:3

Abstract

OBJECTIVES: To examine the effects of 12 weeks aquatic high-intensity interval training (AHIIT) compared with aquatic moderate-intensity continuous training (AMICT) on aerobic capacity and lower limb functional strength in adults with rheumatic and musculoskeletal diseases (RMDs). DESIGN: An assessor-blinded randomised controlled trial. SETTING: Community-based setting. PARTICIPANTS: 89 participants (91% female, mean age 62 (SD 13) years) with RMDs were randomly allocated to AHIIT (n=44) or AMICT (n=45). INTERVENTIONS: Both groups participated in group-based peer-led exercise programmes two times per week for 12 weeks. The AHIIT group included four intervals of 4 min at high intensity (Borg scale 14-18). The AMICT group maintained moderate continuous intensity level (Borg scale 12-13). MAIN OUTCOME MEASURES: Peak aerobic capacity (VO(2)peak) was estimated by time to exhaustion and lower limb functional strength with the 30-second sit-to-stand test (30sSTS) at baseline, 3 months and 6 months. A linear mixed model for repeated measures estimated the mean difference with 95% CI in VO(2)peak and 30sSTS. RESULTS: Mean exercise intensity was Borg scale 15 (SD 2) and 13 (SD 2) in the AHIIT and AMICT, respectively. Mean improvement in VO(2)peak in AHIIT was 1.9 mL∙kg(-1)∙min(-1) (95% CI 0.045 to 3.77) compared with AMICT after 12 weeks (p<0.05). There was no statistically significant difference between groups in VO(2)peak after 6 months or in 30sSTS at either 3 or 6 months (p>0.05). No adverse events during exercise were reported. CONCLUSIONS: AHIIT demonstrated significant improvements in aerobic capacity after 12 weeks, and the intervention was well tolerated with no adverse events reported. However, there was no maintenance of aerobic capacity at 6 months. TRIAL REGISTRATION NUMBER: NCT05209802.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。